About the Company
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CTIC News
CTI BioPharma shares soar 83% after Swedish Orphan Biovitrum announces $1.7 billion deal for the biotech
Swedish Orphan Biovitrum AB, or Sobi, on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma Corp. in a deal valued at $1.7 billion. Shares of CTI soared ...
Cti BioPharma (NASDAQ: CTIC)
CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on ...
Testing for residual cancer cells before blood cell transplant therapy is important and practical, new study finds
Patients with a type of high-risk blood cancer are likely to do better if no trace of the cancer is detectable before they ...
Myelofibrosis: More Than Meets the Eye?
A hallmark clinical manifestation of myelofibrosis is splenomegaly, which reflects splenic extramedullary hematopoiesis (EMH) ...
Sutro Biopharma Inc STRO
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
TBPH Theravance Biopharma, Inc.
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized ...
Sunshine Biopharma Incorporated
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and ...
Arbutus Biopharma Corporation
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus ...
ARCA biopharma, Inc.
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on ...
TBPH Theravance Biopharma, Inc.
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized ...
Loading the latest forecasts...